Posts
November 06 2017
Bio-Path Holdings, Inc. announced the closing of their PIPE in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
November 03 2017
M III Acquisition Corp. announced that it has entered into a definitive agreement and plan of merger with IEA Energy Services LLC, a leading engineering, procurement and construction company in the renewable energy sector. MIII will be renamed as “Infrastructure and Energy Alternatives, Inc.” upon consummation of the merger and is expected to continue to be listed on the Nasdaq Capital Market under the symbol “IEA”. EG&S acted as special SPAC counsel to MIII.
November 03 2017
Nemus Biosciences, Inc. announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to the sole investor.
November 02 2017
Global Partner Acquisition Corp. (“GPAC”) and Purple Innovation, LLC (“Purple”) announced that they have entered into a definitive merger agreement pursuant to which Purple will become a subsidiary of GPAC, based on an initial enterprise value of Purple of approximately $900 million. The consummation of the merger will be subject to the terms and conditions set forth in the agreement. EG&S acted as counsel to GPAC.
October 31 2017
NeuroMetrix Inc. announced the closing of their PIPE offering in the amount of $3,500,000. EG&S acted as counsel to the Lead Investor.
October 30 2017
Atossa Genetics Inc., a clinical-stage pharmaceutical company, announced the closing of its underwritten public offering in the amount of $5,500,000. EG&S acted as counsel to Maxim Group LLC, the sole book-running manager for the offering.
October 27 2017
Social Reality Inc. announced the closing of their PIPE offering in the amount of $5,000,000. EG&S acted as counsel to the Lead Investor.
October 24 2017
Haymaker Acquisition Corp. announced the closing of its initial public offering in the amount of $300,000,000. EG&S acted as counsel to Haymaker.